ME/CFS Research Foundation Logo
Events/ ME/CFS Conference 2023

Immunoadsorption in PCS and ME/CFS

Treatment II
unreveiled person
23-05-11, 11:40 CET, 10 min

Description

An observational study on immunoadsorption in PCS and ME/CFS was the subject of Dr. Stein. In 10 patients* with ME/CFS after COVID-19, a reduction in autoantibodies in the blood was seen after repeated immunoadsorption and was associated with an improvement in physical functioning and a reduction in muscle pain and headaches. Less improvement was seen in fatigue and cognitive functioning. After a few months, however, patients’ overall condition worsened again to reach pre-treatment levels.

Watch video
Download presentation
Interventions
TheraSorb®, Immunoadsorption
Research projects
1
Research areas
3
Research types
1

Research projects

Repeat Immunoadsorption Post Covid ME/​CFS (RIA)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Carmen Scheibenbogen
Organisations:
Charité – University Medicine Berlin
Research period:
2022-08
to 2025-01
Research types:
Clinical research
Research areas:
Immune system dysfunction

Contact

ME/CFS Research Foundation

Ballindamm 27, 20095 Hamburg, Germany

researchregister@mecfs-research.org

Copyright © 2022 ME/CFS Research Foundation
Imprint - Data privacy statement